U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated initiation of Phase 3 program expected in the second ...
The musical genre is helping young offenders at a juvenile detention centre in southern NSW find their voices.